ORANGEVALE, Calif.--(BUSINESS WIRE)--Biomagnetics Diagnostics Corp. (OTC:BMGP), announces today that the company has recently been profiled in international stem cell, genetic engineering and biotechnology publications for their Chinese Biotechnology Initiative and a potential Austrian joint venture involving utilization of BMGP’s technology and Gene Therapeutic Vector Development.
